GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bangkok Lab and Cosmetic PCL (BKK:BLC) » Definitions » Net Income From Continuing Operations

Bangkok Lab and Cosmetic PCL (BKK:BLC) Net Income From Continuing Operations : ฿162 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bangkok Lab and Cosmetic PCL Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Bangkok Lab and Cosmetic PCL's net income from continuing operations for the three months ended in Mar. 2024 was ฿41 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ฿162 Mil.

Bangkok Lab and Cosmetic PCL Net Income From Continuing Operations Historical Data

The historical data trend for Bangkok Lab and Cosmetic PCL's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Lab and Cosmetic PCL Net Income From Continuing Operations Chart

Bangkok Lab and Cosmetic PCL Annual Data
Trend Dec21 Dec22 Dec23
Net Income From Continuing Operations
51.13 129.68 150.82

Bangkok Lab and Cosmetic PCL Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.25 33.41 36.99 50.17 41.16

Bangkok Lab and Cosmetic PCL Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿162 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bangkok Lab and Cosmetic PCL (BKK:BLC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bangkok Lab and Cosmetic PCL (BKK:BLC) » Definitions » Net Income From Continuing Operations
Comparable Companies
BKK:TNR BKK:KISS BKK:SCM BKK:APCO BKK:DDD BKK:BEAUTY BKK:JCT BKK:MOONG BKK:OCC BKK:S&J PG XPAR:OR LSE:ULVR BOM:500696 CL LSE:RKT KMB EL KVUE XTER:BEI
Traded in Other Exchanges
N/A
Address
Nong Chae Sao Road, No. 48/1 Moo 5, Nam Phu, Mueang Ratchaburi, Ratchaburi, Bangkok, THA, 70000
Website
https://www.bangkoklab.co.th
Bangkok Lab and Cosmetic PCL are one of Thailand's comprehensive healthcare solutions groups. Its operation covers the complete value chain of the healthcare business. Its product portfolio comprises generic and new generic drugs, herbal medicines, animal medicines, cosmetics, food supplements, and other health products. Its operation ranges from research and development, manufacturing with international standards, sales, and marketing, to distribution to partnering businesses and customers.

Bangkok Lab and Cosmetic PCL (BKK:BLC) Headlines

No Headlines